Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
A Randomized, Controlled, Evaluator-blinded Study to Evaluate the Efficacy of Dilute Bleach Baths on Skin Disease Control in Pediatric Patients With Atopic Dermatitis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75235
- Children's Medical Center of Dallas
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 2-17 years of age at time of consent. A parent or legal guardian will be required to consent and authorize their enrollment in the study.
- Male or female of any ethnic background.
- English or Spanish speaking.
- A clinical diagnosis of atopic dermatitis for at least 6 months prior to enrollment.
- Must have moderate to severe atopic dermatitis as rated by the EASI score.
- Able to adhere to study visit schedule and other protocol requirements.
- Patients and/or family members must agree to not use any other prescription or over the counter medications other than the ones prescribed by the study protocol.
Exclusion Criteria:
- Clinical evidence of bacterial or viral superinfection on first visit.
- Have received phototherapy within 2 months prior to enrollment.
- Have received any systemic medication for atopic dermatitis or any that may affect evaluation of atopic dermatitis within 2 months prior to enrollment.
- Have a known hypersensitivity response, including anaphylaxis, to any of the topicals used for treatment (i.e. topical steroids, bleach)
- Participation in another clinical trial using an investigational agent or procedure.
- Pregnant or planning pregnancy or surgery during the participation in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Dilute bleach baths
Patients in the intervention group will be instructed to bathe in a dilute bleach bath twice weekly for 10 minutes.
|
Patients in the intervention group will be instructed to bathe in a dilute bleach bath twice weekly for 10 minutes.
|
|
Placebo Comparator: Water
Patients in the placebo group will be instructed to bathe in plain water twice weekly for 10 minutes.
|
Patients in the placebo group will be instructed to bathe in plain water twice weekly for 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eczema Area and Severity Index Score (EASI)
Time Frame: Change in EASI score from baseline at 1 month and 3 month follow ups
|
EASI score is recorded at baseline, 1 month and 3 month follow ups.
|
Change in EASI score from baseline at 1 month and 3 month follow ups
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Investigator's Global Assessment (IGA)
Time Frame: Change in IGA score from baseline at 1 month and 3month follow ups
|
IGA scores are recorded at baseline, 1 month and 3 month follow ups.
|
Change in IGA score from baseline at 1 month and 3month follow ups
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STU 012010-059
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.